Sanjeev Sharma
About Sanjeev Sharma
Sanjeev Sharma is a Senior Vice President at Mirati Therapeutics, with extensive experience in pharmaceutical development. He has held various leadership roles at notable companies, including Pfizer, Onyx Pharmaceuticals, and Abbott, and specializes in novel enabling technologies and contract manufacturing management.
Work at Mirati Therapeutics
Sanjeev Sharma has been serving as Senior Vice President at Mirati Therapeutics since 2017. In this role, he is responsible for overseeing various aspects of the company's operations, particularly in the development of innovative therapies. His extensive experience in the pharmaceutical industry contributes to the strategic direction and operational efficiency of the organization.
Previous Experience in the Pharmaceutical Industry
Before joining Mirati Therapeutics, Sanjeev Sharma held several significant positions in the pharmaceutical sector. He worked at Pfizer as Head of Solids Development from 2004 to 2006. Following that, he served as Senior Director at Onyx Pharmaceuticals, Inc., an Amgen subsidiary, from 2012 to 2014. His career also includes roles at Abbott, Exelixis, Arena Pharmaceuticals, NantKwest, and Monsanto, where he gained diverse expertise across various functions.
Education and Expertise
Sanjeev Sharma possesses expertise in developing novel enabling technologies, including amorphous systems and nano-suspensions. He has a strong background in the selection and management of contract manufacturing organizations, both domestically and internationally. His experience also encompasses the development of metastable forms and strategies to minimize active pharmaceutical ingredient (API) consumption during product development.
Achievements in Pharmaceutical Development
Throughout his career, Sanjeev Sharma has demonstrated a track record of adopting best practices from both large and small pharmaceutical companies. His experience includes laboratory design and build-out for small-scale development, which has contributed to the efficiency and effectiveness of pharmaceutical product development processes.